• 1
    Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 1991;8:1748.
  • 2
    Tagbor HK, Chandramohan D, Greenwood B. The safety of amodiaquine use in pregnant women. Expert Opin Drug Saf 2007;6:6315.
  • 3
    Schirm E, Meijer WM, Tobi H, De Jong-van den Berg LTW. Drug use by pregnant women and comparable non—pregnant women in The Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol 2004;114:1828.
  • 4
    Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of neglected tropical diseases. N Engl J Med 2007;357:101827.
  • 5
    Fenwick A, Webster JP. Schistosomiasis: challenges for control, treatment and drug resistance. Curr Opin Infect Dis 2006;19:57782.
  • 6
    Crawley J, Hill J, Yartey J, Robalo M, Serufilira A, Ba-Nguz A, et al. From evidence to action? Challenges to policy change and programmatic delivery for malaria in pregnancy. Lancet Infect Dis 2007;7:14555.
  • 7
    Malm H, Martikainen J, Klaukka T, Neuvonnen PJ. Prescription of hazardous drugs during pregnancy. Drug Saf 2004;27:899908.
  • 8
    Ouma PO, Van Eijk AM, Hamel MJ, Sikuku E, Odhiambo F, Munguti K, et al. The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya. Trop Med Int Health 2007;12:95361.
  • 9
    Homedes N, Ugalde A. Patients’ compliance with medical treatments in the third world. What do we know? Health Policy Plan 1993;8:291314.
  • 10
    Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992;34:50713.
  • 11
    Campbell JD, Stanford JB, Ewigman B. The social pregnancy interaction model: conceptualizing cognitive, social and cultural barriers to prenatal care. App Behav Sci Rev 1996;4:8197.
  • 12
    Gluckman M. Gossip and Scandal. Curr Anthropol 1963;4:30716.
  • 13
    Gilmore D. Varieties of gossip in a Spanish rural community. Ethnology 1978;17:8999.
  • 14
    Chapman RR. Endangering safe motherhood in Mozambique: prenatal care as pregnancy risk. Soc Sci Med 2003;57:35574.
  • 15
    Peacock NR, Kelley MA, Carpenter C, Davis M, Burnett G, Chavez N, et al. Pregnancy discovery and acceptance among low-income primiparous women: a multicultural exploration. Matern Child Health J 2001;5:10918.
  • 16
    Caelli K, Ray L, Mill J. “Clear as mud: towards greater clarity in generic qualitative research”. Int J Qualitative Methods 2003;2:124.
  • 17
    The Standard Drug Treatment Guidelines, 2nd edn. Banjul, The Gambia: Republic of The Gambia Department of State for Health and Social Welfare, 2001.
  • 18
    Mehta D, editor. British National Formulary. 55th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2008.
  • 19
    Anya SE, Hydara A, Jaiteh LES. Antenatal care in The Gambia: missed opportunity for information, education and communication. BMC Pregnancy Childbirth 2008;8:9.
  • 20
    Lang T, Hughes D, Kanyok T, Kengeya-Kayondo J, Marsh V, Haaland A, et al. Beyond registration—measuring the public health potential of new treatments for malaria in Africa. Lancet Infect Dis 2006;6:4652.
  • 21
    Gyapong JO, Chinbuah MA, Gyapong M. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass administration for lymphatic filariasis. Trop Med Int Health 2003;8:1093101.
  • 22
    Mubyazi G, Bloch P, Kamugisha M, Kitua A, Ijumba J. Intermittent preventive treatment of malaria: a qualitative study of knowledge, attitudes and practices of district health managers, antenatal care staff and pregnancy women in Korogwe District, north-eastern Tanzania. Malar J 2005;4:31.
  • 23
    De Martin S, Von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Trop Med Int Health 2001;6:4428.
  • 24
    Maduka CU, Nweke LN, Miri ES, Amazigo U, Emukah EC, Richards FO. Missed treatment opportunities, for pregnant and breast-feeding women, in onchocerciasis mass-treatment programmes in south-eastern Nigeria. Ann Trop Med Parasitol 2004;98:697702.
  • 25
    Muula AS, Maseko FC. How are health professionals earning their living in Malawi? BMC Health Serv Res 2006;6:97.